Uncategorized

FDA halts release of new drug rejection letters while working to formalize policy

Published

on

The FDA has paused a controversial policy of releasing letters describing its rationale for rejecting drugs, Fierce Biotech has learned, following a citizen’s petition from an unnamed pharma company in April.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version